Skip to main content

Table 4 Medications with frequency Increases ≥ 10% from the baseline to the post-acute phasea by age group

From: Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19

USC Medication Class Description

All Patients (N = 19,558)

Patients Aged 18–64 Years (n = 9381)

Patients Aged ≥ 65 Years (n = 10,177)

Baseline Phase, n (%)

Post-Acute Phase, n (%)

Change From Baseline to Post-Acute Phase, Δ (% Change)

Baseline Phase, n (%)

Post-Acute Phase, n (%)

Change From Baseline to Post-Acute Phase, Δ (% Change)

Baseline Phase, n (%)

Post-Acute Phase, n (%)

Change From Baseline to Post-Acute Phase, Δ (% Change)

Vitamins

771 (3.9)

1137 (5.8)

366 (47.5)

576 (6.1)

663 (7.1)

87 (15.1)

195 (1.9)

474 (4.7)

279 (143.1)

Miscellaneous preparations

831 (4.2)

1147 (5.9)

316 (38.0)

407 (4.3)

546 (5.8)

139 (34.2)

424 (4.2)

601 (5.9)

177 (41.7)

Blood factors

675 (3.5)

888 (4.5)

213 (31.6)

313 (3.3)

368 (3.9)

55 (17.6)

362 (3.6)

520 (5.1)

158 (43.6)

Hemostatic modifiers

2093 (10.7)

2719 (13.9)

626 (29.9)

563 (6.0)

759 (8.1)

196 (34.8)

1530 (15.0)

1960 (19.3)

430 (28.1)

Nutrients and supplements

980 (5.0)

1246 (6.4)

266 (27.1)

340 (3.6)

405 (4.3)

65 (19.1)

640 (6.3)

841 (8.3)

201 (31.4)

Cardiac agents

1203 (6.2)

1485 (7.6)

282 (23.4)

459 (4.9)

529 (5.6)

70 (15.3)

744 (7.3)

956 (9.4)

212 (28.5)

Antineoplastic targeted therapy

536 (2.7)

644 (3.3)

108 (20.1)

183 (2.0)

227 (2.4)

44 (24.0)

353 (3.5)

417 (4.1)

64 (18.1)

Thyroid therapy

2222 (11.4)

2553 (13.1)

331 (14.9)

797 (8.5)

916 (9.8)

119 (14.9)

1425 (14.0)

1637 (16.1)

212 (14.9)

Neurologic/neuromuscular disorders

3790 (19.4)

4271 (21.8)

481 (12.7)

1682 (17.9)

1851 (19.7)

169 (10.0)

2108 (20.7)

2420 (23.8)

312 (14.8)

Gastrointestinal

5002 (25.6)

5595 (28.6)

593 (11.9)

2067 (22.0)

2234 (23.8)

167 (8.1)

2935 (28.8)

3361 (33.0)

426 (14.5)

Psychotherapeutic drugs

5876 (30.0)

6530 (33.4)

654 (11.1)

3150 (33.6)

3366 (35.9)

216 (6.9)

2726 (26.8)

3164 (31.1)

438 (16.1)

Diagnostic aids

3288 (16.8)

3652 (18.7)

364 (11.1)

1428 (15.2)

1582 (16.9)

154 (10.8)

1860 (18.3)

2070 (20.3)

210 (11.3)

  1. USC Uniform System of Classification
  2. aThe baseline period was the 12 months before the index date, and the post-acute phase spanned from 1 to 13 months after the index date